PT955042E - Composicao farmaceutica a base de estrogenio e de progesterona - Google Patents
Composicao farmaceutica a base de estrogenio e de progesteronaInfo
- Publication number
- PT955042E PT955042E PT99401011T PT99401011T PT955042E PT 955042 E PT955042 E PT 955042E PT 99401011 T PT99401011 T PT 99401011T PT 99401011 T PT99401011 T PT 99401011T PT 955042 E PT955042 E PT 955042E
- Authority
- PT
- Portugal
- Prior art keywords
- progesterone
- estrogen
- pharmaceutical composition
- composition based
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9805262A FR2777784B1 (fr) | 1998-04-27 | 1998-04-27 | Composition pharmaceutique a base d'estrogene et de progesterone |
Publications (1)
Publication Number | Publication Date |
---|---|
PT955042E true PT955042E (pt) | 2003-11-28 |
Family
ID=9525714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99401011T PT955042E (pt) | 1998-04-27 | 1999-04-26 | Composicao farmaceutica a base de estrogenio e de progesterona |
Country Status (8)
Country | Link |
---|---|
US (1) | US6165491A (pt) |
EP (1) | EP0955042B1 (pt) |
AT (1) | ATE243507T1 (pt) |
CA (1) | CA2270088C (pt) |
DE (1) | DE69909016T2 (pt) |
ES (1) | ES2201644T3 (pt) |
FR (1) | FR2777784B1 (pt) |
PT (1) | PT955042E (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040167111A1 (en) * | 1998-04-15 | 2004-08-26 | Michael Oettel | Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy |
IL127129A (en) * | 1998-11-18 | 2004-06-01 | Ferring Bv | Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
FR2832065B1 (fr) * | 2001-11-13 | 2004-11-05 | Besins Int Belgique | Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations |
PT1482948E (pt) * | 2002-03-11 | 2006-11-30 | Janssen Pharmaceutica Nv | Terapia de substituição hormonal contínua com progestogénio inibidor de sulfatase |
EP1462106A1 (en) * | 2003-03-28 | 2004-09-29 | Pantarhei Bioscience B.V. | Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders |
GEP20125432B (en) | 2005-10-12 | 2012-03-26 | Unimed Pharmaceuticals Llc | Improved testosterone gel and use thereof |
JP2009523831A (ja) * | 2006-01-20 | 2009-06-25 | ペア トゥリー ファーマシューティカルズ インコーポレイテッド | 萎縮性膣炎を治療する方法 |
BRPI0711525A2 (pt) * | 2006-06-02 | 2011-11-01 | Pear Tree Women S Health Care | composição farmacêutica e método para tratar sintomas de vaginite atrófica |
US8658628B2 (en) * | 2009-06-18 | 2014-02-25 | Karan Y. Baucom | Hormone delivery system and method |
US9795617B2 (en) | 2009-06-18 | 2017-10-24 | Baucom Institute for Longevity and Life Enhancement, Inc. | Hormone delivery system and method |
UY33103A (es) * | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
WO2013078422A2 (en) | 2011-11-23 | 2013-05-30 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2015179782A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
BR112016029338A2 (pt) | 2014-07-29 | 2017-08-22 | Therapeuticsmd Inc | creme transdérmico |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
MX2018011706A (es) * | 2016-04-01 | 2019-06-10 | Therapeuticsmd Inc | Composicion farmaceutica de hormona esteroide. |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
EP3395332A1 (en) * | 2017-04-28 | 2018-10-31 | Chemo Research, S.L. | Hormone softgel capsules and a process for the preparation thereof |
US10285998B1 (en) | 2018-04-04 | 2019-05-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4383993A (en) * | 1980-05-30 | 1983-05-17 | University Of Kentucky Research Foundation | Nasal dosage forms containing natural female sex hormones |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US4447620A (en) * | 1982-06-08 | 1984-05-08 | The Upjohn Company | Imidazolyl-substituted benzothiophenes |
US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
US4900734A (en) * | 1987-08-27 | 1990-02-13 | Maxson Wayne S | Novel pharmaceutical composition containing estradiol and progesterone for oral administration |
US4847276A (en) * | 1988-09-06 | 1989-07-11 | Merrell Dow Pharmaceuticals Inc. | Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione |
DK0393539T3 (da) * | 1989-04-18 | 1993-09-27 | Scherer Gmbh R P | Oral præparatform indeholdende østradiolvalerat |
ES2062191T3 (es) * | 1990-06-14 | 1994-12-16 | Henning Berlin Gmbh | Preparados de capsulas enchufables, rellenos de liquido. |
JPH0517357A (ja) * | 1991-07-05 | 1993-01-26 | Nissan Chem Ind Ltd | 血小板減少療法剤 |
JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
US5424334A (en) * | 1991-12-19 | 1995-06-13 | G. D. Searle & Co. | Peptide mimetic compounds useful as platelet aggregation inhibitors |
US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
SE9301171D0 (sv) * | 1993-04-07 | 1993-04-07 | Ab Astra | Pharmaceutical composition containing lipophilic drugs |
US5445941A (en) * | 1993-06-21 | 1995-08-29 | Eli Lilly And Company | Method for screening anti-osteoporosis agents |
US5391557A (en) * | 1993-10-15 | 1995-02-21 | Eli Lilly And Company | Methods for the treatment of peri-menopausal syndrome |
US5476862A (en) * | 1993-12-21 | 1995-12-19 | Eli Lilly And Company | Methods of increasing thrombomodulin expression |
US5441965A (en) * | 1993-12-21 | 1995-08-15 | Eli Lilly And Company | Methods of inhibiting thrombin |
FR2747042B1 (fr) * | 1996-04-05 | 1998-06-05 | Besins Iscovesco Lab | Medicament a base de progesterone et d'oestradiol |
GB9608719D0 (en) * | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
US6025373A (en) * | 1997-04-22 | 2000-02-15 | Eli Lilly And Company | Methods for reducing fibrinogen |
-
1998
- 1998-04-27 FR FR9805262A patent/FR2777784B1/fr not_active Expired - Fee Related
- 1998-08-03 US US09/128,324 patent/US6165491A/en not_active Expired - Fee Related
-
1999
- 1999-04-26 PT PT99401011T patent/PT955042E/pt unknown
- 1999-04-26 DE DE69909016T patent/DE69909016T2/de not_active Expired - Lifetime
- 1999-04-26 EP EP99401011A patent/EP0955042B1/fr not_active Expired - Lifetime
- 1999-04-26 CA CA002270088A patent/CA2270088C/fr not_active Expired - Fee Related
- 1999-04-26 ES ES99401011T patent/ES2201644T3/es not_active Expired - Lifetime
- 1999-04-26 AT AT99401011T patent/ATE243507T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE243507T1 (de) | 2003-07-15 |
ES2201644T3 (es) | 2004-03-16 |
FR2777784B1 (fr) | 2004-03-19 |
EP0955042B1 (fr) | 2003-06-25 |
CA2270088A1 (fr) | 1999-10-27 |
CA2270088C (fr) | 2003-07-01 |
FR2777784A1 (fr) | 1999-10-29 |
DE69909016D1 (de) | 2003-07-31 |
DE69909016T2 (de) | 2004-05-06 |
US6165491A (en) | 2000-12-26 |
EP0955042A1 (fr) | 1999-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT955042E (pt) | Composicao farmaceutica a base de estrogenio e de progesterona | |
DK0948965T3 (da) | Stabile medicinske præparater indeholdende 4,5-epoxymorphinanderivater | |
IL112235A0 (en) | 8-Aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline 2,3-dione derivatives and pharmaceutical compositions containing them | |
NZ304901A (en) | Taxoid derivatives, preparation thereof and pharmaceutical compositions containing same | |
IL122666A (en) | 3-(5-benzo¬b¾furanyl-4'-alkyl-2'(beta-D-glucopyranosyl)-6'-hydroxypropiophenone derivatives processes for preparing the same and pharmaceutical compositions containing them | |
IL124674A0 (en) | Piperazine derivatives pharmaceutical compositions containing the same and use thereof | |
DE69014351D1 (de) | Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
TW367430B (en) | Copolymers containing N-vinyllactam derivatives, preparation methods thereof and photoresist composition therefrom | |
DE69915693D1 (de) | 2,5-diazabicyclo(2.2.1)heptanderivate, deren herstellung und deren verwendung in heilkunde | |
FR2647343B1 (fr) | Nouvelle forme pharmaceutique poreuse et sa preparation | |
HUP0101475A3 (en) | 4,5,6 and 7-indole and indoline derivatives, their preparation and use | |
GB2336592B (en) | Polymer for photoresist,photoresist composition containing the same,and preparation method thereof | |
EP1334725A3 (fr) | Utilisation d'une composition estroprogestative pour la preparation d'un medicament contraceptif | |
IL121969A0 (en) | 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them | |
ATE181324T1 (de) | Im kardiovaskulären system aktive seco-d-steroide und diese enthaltende pharmazeutische zubereitungen | |
HUP9702480A3 (en) | New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same | |
HU9700842D0 (en) | Pharmaceutical compositions based on stabilized lipophyl matrix giving controlled release for the active components | |
EP0261524A3 (de) | Arzneimittelzubereitungen | |
HUP9702479A3 (en) | New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same | |
IL139962A0 (en) | 4,5,6 and 7-indole and indoline derivatives, their preparation and use | |
AU3076600A (en) | 3,7-disubstituted indole derivatives and medicinal compositions containing the same | |
BR9502704A (pt) | Tablete cápsula ou granulo para administração oral contendo desogestrel e processo para incorporação de um desogestrel e opcionalmente um estrogenio em um solido | |
IL117045A (en) | Substituted N-(2,3-dihydro-1,4-dioxino Ú2,3-b¾pyridine-2-yl) alkanediamine derivatives their preparation and pharmaceutical compositions containing them | |
FR2722094B1 (fr) | Composition orale pour reactiver le bronzage de lapeau a base d'un carotenoide et d'un tocopherol | |
그가 et al. | ht f2003 NuriMedia Co., Ltd. 15 |